Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pim J French

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
IEEE Transactions on Medical Imaging|July 25, 2023
Evaluating the Predictive Value of Glioma Growth Models for Low-Grade Glioma After Tumor ResectionKarin A van Garderen, Sebastian R van der Voort, Maarten M J Wijnenga, et al.
Human Mutation|January 16, 2010
Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of gliomaLonneke A M Gravendeel, Nanne K Kloosterhof, Linda B C Bralten, et al.
Neuro-Oncology|October 10, 2024
Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection-Update 1Martin J van den Bent, Enrico Franceschi, Mehdi Touat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2013
MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951Martin J van den Bent, Lale Erdem-Eraslan, Ahmed Idbaih, et al.
Neuro-Oncology|June 6, 2023
Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guidelineFelix Sahm, Sebastian Brandner, Luca Bertero, et al.
Oncotarget|July 3, 2018
Prognostic stratification of adult primary glioblastoma multiforme patients based on their tumor gene amplification profilesMaría González-Tablas, Inês Crespo, Ana Luísa Vital, et al.
Ebiomedicine|November 8, 2021
Continued androgen signalling inhibition improves cabazitaxel efficacy in prostate cancerLisanne Mout, Martin E van Royen, Corrina de Ridder, et al.
Neuro-Oncology|October 11, 2017
The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysisMaarten M J Wijnenga, Pim J French, Hendrikus J Dubbink, et al.
Acta Neuropathologica|February 24, 2012
Subgroup-specific alternative splicing in medulloblastomaAdrian M Dubuc, A Sorana Morrissy, Nanne K Kloosterhof, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2012
Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951Lale Erdem-Eraslan, Lonneke A Gravendeel, Johan de Rooi, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
IEEE Transactions on Medical Imaging|July 25, 2023
Evaluating the Predictive Value of Glioma Growth Models for Low-Grade Glioma After Tumor ResectionKarin A van Garderen, Sebastian R van der Voort, Maarten M J Wijnenga, et al.
Human Mutation|January 16, 2010
Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of gliomaLonneke A M Gravendeel, Nanne K Kloosterhof, Linda B C Bralten, et al.
Neuro-Oncology|October 10, 2024
Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection-Update 1Martin J van den Bent, Enrico Franceschi, Mehdi Touat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2013
MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951Martin J van den Bent, Lale Erdem-Eraslan, Ahmed Idbaih, et al.
Neuro-Oncology|June 6, 2023
Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guidelineFelix Sahm, Sebastian Brandner, Luca Bertero, et al.
Oncotarget|July 3, 2018
Prognostic stratification of adult primary glioblastoma multiforme patients based on their tumor gene amplification profilesMaría González-Tablas, Inês Crespo, Ana Luísa Vital, et al.
Ebiomedicine|November 8, 2021
Continued androgen signalling inhibition improves cabazitaxel efficacy in prostate cancerLisanne Mout, Martin E van Royen, Corrina de Ridder, et al.
Neuro-Oncology|October 11, 2017
The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysisMaarten M J Wijnenga, Pim J French, Hendrikus J Dubbink, et al.
Acta Neuropathologica|February 24, 2012
Subgroup-specific alternative splicing in medulloblastomaAdrian M Dubuc, A Sorana Morrissy, Nanne K Kloosterhof, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2012
Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951Lale Erdem-Eraslan, Lonneke A Gravendeel, Johan de Rooi, et al.
Pageof 13